Pancreatic Cancer Research

ResearcherNagoya UniversityActive in the last 2 years

Shinji Naganawa

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0214-613X; OpenAlex author ID A5022186242, A5147835198. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
24
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 4

  1. Clinical Outcomes of Gemcitabine Plus Nab-Paclitaxel-Based Chemoradiotherapy in a Multidisciplinary Treatment Strategy for Locally Advanced Pancreatic Cancer (… Co-author DOI 10.1002/ijc.70801↗
  2. Phase II study of chemoradiotherapy combined with gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic ductal adenocarcinoma (NUPAT 05 … Co-author DOI 10.18999/nagjms.81.2.233↗
  3. Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer. Co-author DOI 10.1007/s00280-018-3554-3↗
  4. Limited efficacy of (18)F-FDG PET/CT for differentiation between metastasis-free pancreatic cancer and mass-forming pancreatitis. Last author DOI 10.1097/rlu.0b013e3182817d9d↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Masamichi Hayashi · 3 shared papers, 2018–2026 · strength 0.36
  2. Hiroki Kawashima · 3 shared papers, 2018–2026 · strength 0.36
  3. Junpei Yamaguchi · 3 shared papers, 2018–2026 · strength 0.36
  4. Yukihiro Yokoyama · 3 shared papers, 2018–2026 · strength 0.36
  5. Osamu Maeda · 3 shared papers, 2018–2026 · strength 0.36
  6. Tsutomu Fujii · 3 shared papers, 2018–2026 · strength 0.36
  7. Mitsuro Kanda · 1 shared paper, 2026 · strength 0.22
  8. Haruyoshi Tanaka · 1 shared paper, 2026 · strength 0.22
  9. Nobuhiko Nakagawa · 1 shared paper, 2026 · strength 0.22
  10. Hironori Yamada · 1 shared paper, 2026 · strength 0.22
  11. Tomoki Ebata · 1 shared paper, 2026 · strength 0.22
  12. Yukio Ando · 2 shared papers, 2018–2019 · strength 0.13
  13. Masato Nagino · 2 shared papers, 2018–2019 · strength 0.13
  14. Hidemi Goto · 2 shared papers, 2018–2019 · strength 0.13
  15. Nao Takano · 2 shared papers, 2018–2019 · strength 0.13
  16. Suguru Yamada · 2 shared papers, 2018–2019 · strength 0.13
  17. Yasuhiro Kodera · 2 shared papers, 2018–2019 · strength 0.13
  18. Yoshiki Hirooka · 2 shared papers, 2018–2019 · strength 0.13
  19. Masaya Suenaga · 1 shared paper, 2019 · strength 0.07
  20. Takuya Ishikawa · 1 shared paper, 2019 · strength 0.07
  21. Fuminori Sonohara · 1 shared paper, 2019 · strength 0.07
  22. Eizaburo Ohno · 1 shared paper, 2019 · strength 0.07
  23. Akihiro Hirakawa · 1 shared paper, 2019 · strength 0.07
  24. Katsuhiko Kato · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.